checkAd
    Startseite > Aktien > Akoya Biosciences > Nachrichten
    Akoya Biosciences Aktie
    4,0400
     
    USD
    +1,25 %
    +0,0500 USD
    Letzter Kurs 03.05.24 Nasdaq
    4,0400
     
    USD
    800 STK
    Geldkurs 03.05.24
    4,0500
     
    USD
    300 STK
    Briefkurs 03.05.24
    ISIN: US00974H1041 · WKN: A3CM1B · SYM: AKYA · USA

    Neueste Nachrichten

    Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows
    02.05.24 · globenewswire · Akoya Biosciences
    Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
    22.04.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale
    05.04.24 · globenewswire · Akoya Biosciences
    Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook
    04.03.24 · globenewswire · Akoya Biosciences
    Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference
    08.02.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences’ Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases
    18.01.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board
    10.01.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow
    07.01.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook
    07.01.24 · globenewswire · Akoya Biosciences
    Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform
    07.01.24 · globenewswire · Akoya Biosciences
    Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference
    20.12.23 · globenewswire · Akoya Biosciences
    Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
    08.11.23 · globenewswire · Akoya Biosciences